WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999039647) APPARATUS AND METHOD FOR INHIBITING RESTENOSIS BY APPLYING ULTRASOUND ENERGY TOGETHER WITH DRUGS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/039647    International Application No.:    PCT/US1999/002332
Publication Date: 12.08.1999 International Filing Date: 03.02.1999
Chapter 2 Demand Filed:    09.09.1999    
IPC:
A61B 17/22 (2006.01), A61M 37/00 (2006.01)
Applicants: ANGIOSONICS, INC. [US/US]; Suite 207 2200 Gateway Center Boulevard Morrisville, NC 27560 (US)
Inventors: ROSENSCHEIN, Uri; (IL).
ROZESZJAN, Arie; (IL)
Agent: ROSENTHAL, Lawrence; 180 Maiden Lane New York, NY 10038 (US)
Priority Data:
09/021,162 10.02.1998 US
Title (EN) APPARATUS AND METHOD FOR INHIBITING RESTENOSIS BY APPLYING ULTRASOUND ENERGY TOGETHER WITH DRUGS
(FR) APPAREIL ET PROCEDE D'INHIBITION DE RESTENOSE PAR APPLICATION D'ENERGIE ULTRASONORE EN COMBINAISON AVEC DES MEDICAMENTS
Abstract: front page image
(EN)A system and method for inhibiting restenosis by compromising the migration, viability and adhesion of mammalian smooth muscle cells (SMC). The system includes an ultrasonic energy source; a transmitter for transmitting the ultrasonic energy to the SMC and a drug delivery spectrum for delivering drugs to the smooth mucles cells. This system and method is especially useful in the prevention of restenosis in a blood vessel of a mammal associated with the migration of SMC in the blood vessel following vascular intervention, such as angioplasty.
(FR)L'invention concerne un système et un procédé permettant d'inhiber une resténose en empêchant la migration, la viabilité et l'adhérence de cellules musculaires lisses (SMC) de mammaliens. Le système comprend une source d'énergie ultrasonore; un émetteur destiné à émettre l'énergie ultrasonore vers les SMC et un spectre d'administration de médicaments permettant d'introduire les médicaments dans les cellules musculaires lisses. Ces système et procédé sont notamment utiles pour la prévention d'une resténose dans le vaisseau sanguin d'un mammalien associée à la migration de SMC dans le vaisseau sanguin suite à une intervention vasculaire, telle qu'une angioplastie.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)